Basaglar is indicated to improve glycaemic ... Sanofi's blockbuster Lantus and was tentatively approved for use with KwikPen, a pre-filled dosing device. Lantus goes off patent from February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback